Investment Firm
Overview
LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy
Dec 19, 2022
Series Unknown
Highlights
Location
Social
Participant Investors
1
Investor Name |
---|
Starbloom Capital |
LIfT BioSciences raised an undisclosed amount on 2022-12-19 in Venture Round
LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy
Company Funding History
5
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Aug 14, 2019 | Series A - LIfT BioSciences | 2 | - | 2.4M |
May 24, 2018 | Non Equity Assistance - LIfT BioSciences | 1 | - | undefined |
Dec 19, 2022 | Venture Round - LIfT BioSciences | 1 | - | undefined |
May 16, 2024 | Grant - LIfT BioSciences | 1 | - | 1.3M |
Recent Activity
There is no recent news or activity for this profile.